Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
If TRIUMPH-3 is not complete by the time of submission, the FDA may require Lilly to submit that data as a post-marketing commitment, which would allow approval to proceed but with conditions
Hdac inhibition prevents nf-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha
Your body relies on Vitamin B12 to make red blood cells, produce immune cells, support your nervous system and neurological function, and assist in DNA synthesis
GI side effects like nausea or constipation affect about 30% of users initially, but resolve within 24 weeks for most people and can be managed with dose adjustment and dietary fiber
Cruz-Jentoft AJ, Dawson Hughes B, Scott D, Sanders KM, Rizzoli R